Variant syndromes in autoimmune hepatic diseases;Sindromi varianti nelle epatopatie autoimmuni

Minerva Gastroenterologica e Dietologica

Volumn 47, Issue 1, 2001, Pages 27-38

  Durazzo, M ^a   Bresso, F ^a   Premoli, A ^a   Rabbione, L ^a  

^a Dipartimento di Medicina Interna   (Italy)

Author keywords

Cholangitis, sclerosing; Hepatitis, autoimmune; Liver cirrhosis, bidiary

Indexed keywords

INTERFERON;

AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; HUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SYNDROME;

EID: 84873514231     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Primary biliary cirrhosis: Paradigm or paradox for autoimmunity
2. Molecular mimicry in liver disease
3. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): Characterization of the main immunogenic region
4. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis
5. Antimitochondrial antibody and other immunological tests in primary biliary cirrhosis
6. Autoimmune tests in primary biliary cirrhosis
7. The epidemiology of primary biliary cirrhosis: Immunological problems
8. Familial primary biliary cirrhosis
9. Familial primary biliary cirrhosis reassessed: A geographically-based population study
10. Familial primary biliary cirrhosis in Hiroschima
11. Prevalence and pattern of familial disease in primary biliary cirrhosis
12. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis
13. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: Antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members
14. Primary biliary cirrhosis: Survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years
15. Controlled clinical trials: The controls are the key
16. Neutrophil cytoplasmic antibodies: A link between primary sclerosing, cholangitis and ulcerative colitis
17. Susceptibility to autoimmune chronic active hepatitis: Human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors
18. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis
19. Drug therapy in the management of autoimmune hepatitis 1
20. A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)
21. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
22. AMA negative primary biliary rirrhosis: A distinct sindrome of autoimmune cholangitis
23. Autoimmune cholangitis: A variant of primary bilairy cirrhosis
24. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis
25. Comparison of the clinical features and the clinical course of antimitochondrial antibodies-positive and -negative primary biliary cirrhosis
26. Autoimmune cholangitis and primary biliary cirrhosis - An autoimmune enigma
27. Autoimmune Cholangiopaty: Part of the spectrum of chronic autoimmune active hepatitis
28. The variant forms of autoimmune hepatitis
29. Ludwig Symposium on biliary disorders. Autoimmune cholangitis: A unique entity?
30. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
31. Autoimmune cholangitis within the spectrum of autoimmune liver disease
32. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
33. Autoimmunity induced by interferon-α therapy for chronic viral hepatitis
34. Does antimicronial antibodies status affect response to treatment in patients with primary biliary cirrhosis? Outcames of ursodeoxycholic acid therapy and liver transplantation
35. Responses to treatment can differentiate chronic active liver disease with cholangitis features from the primary biliary cirrhosis syndrome
36. Chronic active hepatitis with cholestatic features. A clinical and immunological study
37. Frequency and significance in antimitochrondrial antibodies in severe chronic active hepatitis
38. Frequency and nature of the variant sindromes of autoimmune liver disease
39. Characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: Evidence for it being a hepatitic form of primary biliary cirrhosis in genetically susceptible individuals
40. Primary biliary cirrhosis
41. Autoimmune hepatits
42. The hepatits-associated bile duct lesion
43. Autoimmune cholangiopaty: The result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
44. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
45. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acid in the mause
46. Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line
47. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation on 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
48. Allelic sequence variation in the autoimmune hepatitis class II genes and proteins in patients with autoimmune hepatitis
49. Increased frequency of HLADRB3*0101(DR52a) associated DQA1,DQB1 haplotypes in primary sclerosing cholangitis
50. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
51. Autoimmune hepatitis in childwood: A 20 year experience
52. Primary sclerosing cholangitis in childwood
53. Primary sclerosing cholangitis in 32 children: Clinical laboratory and radiografic features with survival analysis
54. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in 5 cases
55. Overlap of autoimmune hepatitis e primary sclerosing cholangitis: An evaluation of a modified scoring system
56. Meeting report: International autoimmune hepatitis group
57. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
58. A 39 year old man with chronic hepatitis
59. A 28-year-old woman with a combined hepatitic cholestatic syndrome
60. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
61. An atypical presentation for PSC
62. A spectrum of histopathologic findings in autoimmune liver disease
63. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dionysos cohort
64. LKM1 antibodies recognize a short linear sequence in P450IID6, a cytochrome P450 monooxygenase
65. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection
66. Anti-GOR and hepatitis C virus in autoimmune liver disease
67. Liver/kidney microsome antibody type 1 and hepatitis C virus infection
68. The validity and importance of subtypes in autoimmune hepatitis: A point of view
69. Efficacy and safety of interferon-α therapy in chronic hepatitis C with autoantibodies to liver kidney microsomes
70. Autoimmune forms of chronic hepatitis associated with hepatitis C virus (HCV) infection with and without HCV-RNA: Histological differences from pure autoimmune hepatitis and chronic hepatitis C
71. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis